Team claims breakthrough in sea-based medicines

07/1/2005 | Courier-Mail (Brisbane, Australia), The

International scientists say they have cloned DNA from marine organisms into E. coli bacteria in an effort to create a sustainable supply of new drugs, a problem that has held back marine-derived drug development in the past. One of the group's leaders says drug companies have been reluctant to invest large amounts of money in the past because the need to return to the sea to get enough organisms, such as sponges, to meet global demand proved to be ecologically unsound.

View Full Article in:

Courier-Mail (Brisbane, Australia), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN